The post ESMA executive director says tokenized stocks could mislead investors appeared on BitcoinEthereumNews.com. European Securities and Markets Authority (ESMA) executive, Natasha Cazenave, has raised an issue regarding how tokenized stocks are being presented to investors, warning that it could lead to misunderstandings. The European Securities and Markets Authority continues to maintain that while financial innovation can offer benefits, it must not come at the expense of market stability. ESMA executive warns that tokenized stocks could mislead investors According to the European Union’s securities watchdog, tokenized stocks could lead to “investor misunderstanding,” as they often do not make buyers genuine shareholders in the companies they track. These tokenized stocks are digital assets that mirror the price of publicly listed shares, and they have been gaining attention in the European Union following recent launches by trading platforms. Robinhood, the broker, has introduced tokenized stock offerings in the EU, while the cryptocurrency exchange, Coinbase, is also dipping its toes in the sector. ESMA’s executive director, Natasha Cazenave, raised the issue on Monday about how these offerings are being presented to retail investors. She stressed the importance of transparency and safeguards as the adoption of tokenized stocks spreads at a financial conference in Dubrovnik. “These tokenized instruments can provide always-on access and fractionalisation but typically do not confer shareholder rights. This can create a specific risk of investor misunderstanding,” Cazenave said. She went on to urge for clarity and safeguards. The lack of shareholder rights is a red flag The problem is that, unlike conventional share purchases, tokenized stocks usually do not grant holders ownership rights such as voting privileges or dividend entitlements. In many cases, the securities are held by middlemen through special-purpose vehicles, while the tokens just track the price movements of the actual stock. The convenience of fractionalized, 24/7 trading may make tokenized stock offerings seem appealing to smaller investors, but without proper clarity… The post ESMA executive director says tokenized stocks could mislead investors appeared on BitcoinEthereumNews.com. European Securities and Markets Authority (ESMA) executive, Natasha Cazenave, has raised an issue regarding how tokenized stocks are being presented to investors, warning that it could lead to misunderstandings. The European Securities and Markets Authority continues to maintain that while financial innovation can offer benefits, it must not come at the expense of market stability. ESMA executive warns that tokenized stocks could mislead investors According to the European Union’s securities watchdog, tokenized stocks could lead to “investor misunderstanding,” as they often do not make buyers genuine shareholders in the companies they track. These tokenized stocks are digital assets that mirror the price of publicly listed shares, and they have been gaining attention in the European Union following recent launches by trading platforms. Robinhood, the broker, has introduced tokenized stock offerings in the EU, while the cryptocurrency exchange, Coinbase, is also dipping its toes in the sector. ESMA’s executive director, Natasha Cazenave, raised the issue on Monday about how these offerings are being presented to retail investors. She stressed the importance of transparency and safeguards as the adoption of tokenized stocks spreads at a financial conference in Dubrovnik. “These tokenized instruments can provide always-on access and fractionalisation but typically do not confer shareholder rights. This can create a specific risk of investor misunderstanding,” Cazenave said. She went on to urge for clarity and safeguards. The lack of shareholder rights is a red flag The problem is that, unlike conventional share purchases, tokenized stocks usually do not grant holders ownership rights such as voting privileges or dividend entitlements. In many cases, the securities are held by middlemen through special-purpose vehicles, while the tokens just track the price movements of the actual stock. The convenience of fractionalized, 24/7 trading may make tokenized stock offerings seem appealing to smaller investors, but without proper clarity…

ESMA executive director says tokenized stocks could mislead investors

European Securities and Markets Authority (ESMA) executive, Natasha Cazenave, has raised an issue regarding how tokenized stocks are being presented to investors, warning that it could lead to misunderstandings.

The European Securities and Markets Authority continues to maintain that while financial innovation can offer benefits, it must not come at the expense of market stability.

ESMA executive warns that tokenized stocks could mislead investors

According to the European Union’s securities watchdog, tokenized stocks could lead to “investor misunderstanding,” as they often do not make buyers genuine shareholders in the companies they track.

These tokenized stocks are digital assets that mirror the price of publicly listed shares, and they have been gaining attention in the European Union following recent launches by trading platforms.

Robinhood, the broker, has introduced tokenized stock offerings in the EU, while the cryptocurrency exchange, Coinbase, is also dipping its toes in the sector.

ESMA’s executive director, Natasha Cazenave, raised the issue on Monday about how these offerings are being presented to retail investors. She stressed the importance of transparency and safeguards as the adoption of tokenized stocks spreads at a financial conference in Dubrovnik.

“These tokenized instruments can provide always-on access and fractionalisation but typically do not confer shareholder rights. This can create a specific risk of investor misunderstanding,” Cazenave said.

She went on to urge for clarity and safeguards.

The lack of shareholder rights is a red flag

The problem is that, unlike conventional share purchases, tokenized stocks usually do not grant holders ownership rights such as voting privileges or dividend entitlements.

In many cases, the securities are held by middlemen through special-purpose vehicles, while the tokens just track the price movements of the actual stock.

The convenience of fractionalized, 24/7 trading may make tokenized stock offerings seem appealing to smaller investors, but without proper clarity on how these offerings work, many could mistakenly assume they are acquiring actual shares in the underlying company.

The World Federation of Exchanges (WFE) also addressed the issue last week, urging regulators to crack down on tokenized stocks. They warned that tokenized stocks pose new dangers to investors and could affect market integrity if left unchecked.

Supporters of tokenization continue to argue, however, that by converting traditional assets such as bank deposits, bonds, funds, and even real estate into tradeable digital tokens, tokenization can expand access, lower costs, and improve efficiency.

Cazenave acknowledged that tokenization carries the possibility of efficiency gains in capital markets. However, she cautioned that the reality of current projects does not reflect these possibilities.

“Most tokenization initiatives remain small and largely illiquid so far,” she said.

If you’re reading this, you’re already ahead. Stay there with our newsletter.

Source: https://www.cryptopolitan.com/esma-says-tokenized-stocks-mislead-investors/

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23